脓毒症合并高动力型左心室射血分数ICU患者的原因及预后分析
该回顾性队列研究纳入2018年1月至2021年10月江苏大学附属人民医院重症医学科收治的脓毒症患者,最终253例纳入分析,按ICU入科7天内经胸超声心动图LVEF分为正常LVEF组(0.55-0.70,169例)、低LVEF组(<0.55,40例)和高动力型LVEF组(>0.70,44例)。高动力型LVEF组90天死亡率59.1%(26/44)显著高于正常LVEF组的24.9%(42/169)和低LVEF组的32.5%(13/40)(均P<0.05)。多因素Logistic回归显示慢性肝病、肿瘤、心率、血管活性药物剂量和有创机械通气是高动力型LVEF的独立因素。作者认为高动力型LVEF与脓毒症死亡率正相关,可能与脓毒症血管麻痹导致SVR下降有关。
要点
- 高动力型LVEF组(LVEF>0.70)90天死亡率为59.1%(26/44),显著高于正常LVEF组24.9%(42/169)和低LVEF组32.5%(13/40)(均P<0.05)。
- 多因素Logistic回归显示慢性肝病(OR=1.712,95%CI 0.912-3.234,P<0.001)、肿瘤(OR=2.784,95%CI 1.296-6.151,P<0.001)、心率(OR=1.026,95%CI 1.014-1.038,P<0.001)、血管活性药物剂量(OR=1.133,95%CI 1.009-1.291,P<0.001)和有创机械通气(OR=2.141,95%CI
- 高动力型LVEF组患者SV和CI高于正常LVEF组和低LVEF组,SVR低于正常LVEF组和低LVEF组,E/A比值升高。
- 相关性分析显示高动力型LVEF患者死亡率与SVR呈负相关(r=-0.545,P<0.001)。
- 高动力型、正常LVEF和低LVEF患者死亡率均与血管活性药物剂量呈正相关(r分别为0.251、0.361、0.289,均P<0.001)。
适用人群与场景
- 江苏大学附属人民医院重症医学科2018年1月至2021年10月收治的脓毒症患者。
- 排除入科时存在严重瓣膜病或心肌病的患者以及ICU入科7天内未完成心脏超声检查的患者,最终纳入253例。
诊断标准与关键阈值
- 根据ICU入科7天内经胸超声心动图检查结果分组:正常LVEF组LVEF 0.55-0.70,低LVEF组LVEF<0.55,高动力型LVEF组LVEF>0.70。
研究设计与关键结果
- 研究类型为回顾性队列研究,最终纳入253例脓毒症患者,分为正常LVEF组169例、低LVEF组40例和高动力型LVEF组44例。
- 高动力型LVEF组90天死亡率为59.1%(26/44),显著高于正常LVEF组的24.9%(42/169)和低LVEF组的32.5%(13/40),均P<0.05。
- 高动力型LVEF组SV和CI高于正常LVEF组和低LVEF组,SVR低于正常LVEF组和低LVEF组,E/A比值升高。
- 多因素Logistic回归显示慢性肝病(OR=1.712,95%CI 0.912-3.234,P<0.001)、肿瘤(OR=2.784,95%CI 1.296-6.151,P<0.001)、心率(OR=1.026,95%CI 1.014-1.038,P<0.001)、血管活性药物剂量(OR=1.133,95%CI 1.009-1.291,P<0.001)和有创机械通气(OR=2.141,95%CI 1.285-3.651,P<0.001)是脓毒症患者发生高动力型LVEF的独立因素。
- 相关性分析显示高动力型LVEF患者死亡率与SVR呈负相关(r=-0.545,P<0.001),高动力型、正常LVEF和低LVEF患者死亡率均与血管活性药物剂量呈正相关(r分别为0.251、0.361、0.289,均P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为慢性肝病、肿瘤、心率、血管活性药物剂量和有创机械通气是脓毒症患者发生高动力型LVEF的独立危险因素。
- 作者认为高动力型LVEF与脓毒症患者死亡率正相关,可能与脓毒症血管麻痹导致SVR下降有关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the causes of hyperdynamic left ventricular ejection fraction (LVEF) in sepsis patients in the intensive care unit (ICU) and its impact on prognosis.
METHODS: A retrospective cohort study was conducted. The clinical data of 273 sepsis patients admitted to the department of critical care medicine of the Affiliated People's Hospital of Jiangsu University from January 2018 to October 2021 were collected including gender, age, severity score, comorbidities, source of infection, vital signs, transthoracic echocardiographic (TTE) parameters, fluid intake and output, vasoactive drug dose, therapeutic measures and prognostic indicators. The patients were divided into normal LVEF group (LVEF 0.55-0.70), low LVEF group (LVEF < 0.55) and hyperdynamic LVEF group (LVEF > 0.70) according to the TTE examination results within 7 days of ICU admission. The clinical indicators among the three groups were compared and analyzed, and multivariate Logistic regression analysis was used to screen risk factors for the development of hyperdynamic LVEF in patients with sepsis. Spearman correlation analysis was used to determine the correlation between the mortality of different types of LVEF and clinical variables.
RESULTS: Among 273 patients, 20 patients with severe valvular or cardiomyopathy at admission and those who did not completed cardiac ultrasound within 7 days of ICU admission were excluded. A total of 253 patients were finally enrolled, including 169 patients in the normal LVEF group, 40 patients in the low LVEF group, and 44 patients in the hyperdynamic LVEF group. There were statistically significant differences in age, sequential organ failure assessment (SOFA) score, central venous pressure (CVP), heart rate (HR), oxygenation index (PaO2/FiO2), blood lactate (Lac), urine output, vasoactive drug dose, ratio of hypertension, ischemic heart disease, chronic liver disease, cancer, invasive mechanical ventilation and renal replacement therapy (RRT), and incidence of septic shock among the different types of LVEF groups. TTE results analysis showed that the hyperdynamic LVEF group had higher stroke volume (SV) and cardiac index (CI) than those in the normal LVEF and low LVEF groups, lower systemic vascular resistance (SVR) than that in the normal LVEF and low LVEF groups, and an increased E/A ratio. The 90-day mortality in the hyperdynamic LVEF group was significantly higher than that in the normal LVEF and low LVEF groups [59.1% (26/44) vs. 24.9% (42/169), 32.5% (13/40), both P < 0.05]. Multivariate Logistic regression analysis showed that chronic liver disease [odds ratio (OR) = 1.712, 95% confidence interval (95%CI) was 0.912-3.234, P < 0.001], cancer (OR = 2.784, 95%CI was 1.296-6.151, P < 0.001), HR (OR = 1.026, 95%CI was 1.014-1.038, P < 0.001), vasoactive drug dose (OR = 1.133, 95%CI was 1.009-1.291, P < 0.001), and invasive mechanical ventilation (OR = 2.141, 95%CI was 1.285-3.651, P < 0.001) were independent factors for hyperdynamic LVEF in ICU sepsis patients. Correlation analysis showed that the mortality of hyperdynamic LVEF, normal LVEF and low LVEF patients was positively correlated with vasoactive drug dose (r value was 0.251, 0.361, 0.289, respectively, all P < 0.001). The mortality of the hyperdynamic LVEF patients was negatively correlated with SVR (r = -0.545, P < 0.001).
CONCLUSIONS: Chronic liver disease, cancer, HR, vasoactive drugs dose, and invasive mechanical ventilation are independent risk factors for hyperdynamic LVEF in patients with sepsis. Hyperdynamic LVEF is positively associated with mortality in sepsis patients, which may be due to the the decrease of SVR caused by septic vascular paralysis.
参考来源
- Xiong F, Yang H, Yan J, et al. [Causes and prognosis analysis of hyperdynamic left ventricular ejection fraction in intensive care unit patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37593862. doi:10.3760/cma.j.cn121430-20220418-00385
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。